In 2024, the in vitro diagnostics (IVD) industry is seeing unprecedented opportunities for growth. This article takes an in-depth look at the latest industry trends.
Driven by Technological Innovation
Chemiluminescence Immunoassay
Chemiluminescence immunoassay is gradually replacing traditional enzyme immunoassay thanks to its high sensitivity and high specificity. Xinke Medical has continued to invest in R&D in chemiluminescence reagents and has launched a number of high-quality reagent products.
Expanding Applications of Flow Cytometry
Flow cytometry is being used more and more widely in clinical testing, expanding from traditional blood cell analysis into immunophenotyping, tumor marker detection and other fields.
Changing Market Landscape
Accelerated Import Substitution
As the technical capabilities of domestic IVD companies improve, locally produced reagents are increasingly replacing imported products. Backed by years of technical expertise, Xinke Medical has become a major supplier of domestic IVD reagents.
Expanding Primary-Care Market
With the support of national policies, the testing capacity of primary healthcare institutions continues to improve, opening up new room for growth in the IVD reagent market.
Future Opportunities
Xinke Medical will continue to deepen its commitment to the IVD field and contribute to the development of the industry.